Introduction
============

The first event leading to the formation of a platelet plug is mediated by the glycoprotein Ib-IX complex (GpIb-IX), the second most-abundant platelet receptor after the integrin αIIbβ3.^[@b1-1051660]--[@b3-1051660]^ Platelet binding to von Willebrand factor (vWF) is tightly controlled in order to occur only at sites of bleeding but not in the normal circulation, where it would cause thrombosis. This regulation involves activation of vWF only at high flow rates and binding of GpIb to the A1 domain of vWF through a two-step mechanism, in which a vWF multimer first elongates, then the A1 domain transitions to a high-affinity state.^[@b4-1051660]--[@b6-1051660]^ The role of high-shear flow in the pathogenesis of thrombosis is particularly relevant under pathological conditions such as in stenosed, atherosclerotic arteries, where shear stress can increase above 100 dyn/cm^2^ (shear rate \>4000/s).^[@b7-1051660],[@b8-1051660]^ Because of its pivotal role in initiating platelet adhesion, GpIb represents a promising antithrombotic target.

Omega-3 fatty acids (n-3 FA) are a class of naturally occurring polyunsaturated fatty acids that include the plant-derived α-linolenic acid (ALA), whose cardioprotective effects have been shown by us and others,^[@b9-1051660]--[@b12-1051660]^ which is readily available and marine-derived n-3 FA, whose use is restricted by limited fishery resources and sea pollution.^[@b13-1051660]--[@b15-1051660]^ n-3 FA modulate cellular responses through incorporation into plasma membranes and reduction in the formation of typical protein complexes/lipid rafts, among other effects.^[@b16-1051660]--[@b18-1051660]^ Based on our previous observations that ALA reduces platelet reactivity,^[@b10-1051660],[@b19-1051660]^ and on studies showing the presence of GpIb in lipid rafts,^[@b20-1051660]--[@b22-1051660]^ we hypothesized that ALA might interfere with the distribution of GpIb on the plasma membrane in high-shear flow and, therefore, alter binding to vWF.

Methods
=======

Blood samples
-------------

Blood from healthy volunteers was obtained from the Blood Center of the Swiss Red Cross at the Cantonal Hospital Baden with informed consent according to the Declaration of Helsinki. The study was approved by the Institutional Review Board. EDTA or citrated blood was kept at room temperature until assays were performed (within 2 h of drawing). Blood was incubated with vehicle (0.1% ethanol) or ALA 30 μM for 1 h at room temperature before being used for subsequent experiments. The n-3 FA dose was chosen based on a previous study showing this to be a dietary reachable concentration.^[@b23-1051660]^ Platelet adhesion to vWF was performed on a Bioflux 200 system (Fluxion Bioscience, San Francisco, CA, USA) according to the manufacturer's protocol (see the *Online Supplementary Data* file for details).

Immunofluorescence staining for ground state depletion microscopy
-----------------------------------------------------------------

Washed platelets isolated from vehicle or ALA-treated samples were fixed with 4% paraformaldehyde for 15 min, then spun on a 1.5 coverslip in a Cytospin (Thermo Fisher Scientific, Waltham, MA, USA) and stained for ground state depletion (GSD) microscopy. For details, see the *Online Supplementary Data* file.

Flow cytometric analysis of von Willebrand factor binding
---------------------------------------------------------

Platelet-rich plasma or washed platelets from vehicle- or ALA-treated blood samples were fixed with 4% paraformaldehyde for 15 min, then incubated with 1% bovine serum albumin (BSA) in phosphate-buffered saline (PBS) containing a rabbit anti-human vWF antibody (1:500, Dako A0082) and an anti-GpIbα-APC (BD Bioscience, San Jose, CA, USA) for 1 h. In some experiments, exogenous human vWF (100 ug/mL, Hematologic Technologies) was added to washed platelets. Samples were washed three times in 1% BSA in PBS and then stained with anti-rabbit 488 (1:250, Jackson Immunoresearch, West Grove, PA, USA) for 30 min. After three washes in 1% BSA in PBS, samples were resuspended in 300 mL PBS and analyzed on a LSR Fortessa (BD Bioscience).

Cryo-electron tomography
------------------------

Resting and sheared platelets in Tyrode buffer were seeded on gold grids coated with a silicon mesh (R 1/4, 200 mesh, Quantifoil, Jena, Germany). Platelets were allowed to adhere for 10 min and then fixed with 4% formaldehyde for 5 min at room temperature, before being processed for cryo-ET. GpIb and integrin αIIbβ3 receptors were detected by immunogold labeling (details are given in the *Online Supplementary Data*). Data were acquired using an FEI Titan Krios. Tomograms were acquired with a magnification of 42,000× corresponding to a pixel size of 0.34 nm. The receptor density was analyzed using MATLAB scripts and the receptor distributions were plotted and statistically analyzed by OriginLab software (Northampton, MA, USA).

Statistical analysis
--------------------

Data are plotted as the mean ± standard error of mean of at least three independent experiments. They were analyzed by a paired, two-tailed Student *t*-test with GraphPad Prism version 7 (GraphPad Software, La Jolla, CA, USA). *P* values \<0.05 were considered statistically significant.

Results
=======

Pre-incubation of blood with the n-3 FA ALA at dietary relevant concentrations^[@b23-1051660]^ reduced the GpIb/vWF interaction under pathological high-shear flow (10,000 s^−1^, corresponding to the flow rate in an 80% stenosed artery), as measured by the platelet-covered area (106,963±15,892 μm^2^ with vehicle *vs*. 75,519±16,254 μm^2^ with ALA) ([Figure 1A, B](#f1-1051660){ref-type="fig"} and *Online Supplementary Videos S1 and S2*). Analysis of single fluorescently labeled platelets showed that their speed was doubled when pre-incubated with ALA ([Figure 1C](#f1-1051660){ref-type="fig"}), while the distance traveled before stopping was increased (8.89±4.0 μm with vehicle *vs*. 13.36±7.2 μm with ALA) ([Figure 1D, E](#f1-1051660){ref-type="fig"}).

![Platelet adhesion to von Willebrand factor is inhibited by α-linolenic acid. Blood collected into EDTA and pre-incubated with vehicle or α-linolenic acid (ALA) for 1 h was perfused on von Willebrand factor (vWF) at high-shear rate and platelet adhesion monitored by fluorescence microscopy. Platelet-covered area measured at the end of the perfusion (A) or every minute during the perfusion (B) was significantly reduced by the ALA treatment (n=6, *P*=0.0039). The first time-point in B corresponds to 5 s after the start of the flow. (C) Single platelet rolling velocity measurements showed an increased speed in the ALA-treated samples, and a correspondingly increased distance until firm adhesion (D) (n=6, *P*=0.04 for C and *P*=0.0009 for D). (E) Representative projection images of a vehicle (VEH)- or ALA-treated sample showing single platelets rolling over vWF. (F) Membrane cholesterol depletion by pre-incubation of EDTA-blood with methyl-β cyclodextrin MbCD) completely abolished platelet adhesion to vWF (n=6, *P*\<0.0001).](1051660.fig1){#f1-1051660}

It has been reported that GpIb resides in cholesterol-rich membrane domains termed lipid rafts,^[@b20-1051660],[@b21-1051660],[@b24-1051660],[@b25-1051660]^ and that it appears to cluster in conditions of high-shear flow.^[@b22-1051660]^ In agreement with these findings, cholesterol depletion with methyl-β-cyclodextrin (MβCD), able to remove 50-90% of membrane cholesterol,^[@b26-1051660]^ greatly reduced platelet adhesion to vWF, demonstrating the pivotal role of membrane cholesterol in GpIb-vWF adhesion under high-shear flow (188±16 μm^2^) ([Figure 1F](#f1-1051660){ref-type="fig"}).

To exclude that the reduced adhesion of ALA-treated platelets was due to lower levels of membrane GpIb, vehicle- and ALA-treated washed platelets were exposed to high-shear flow in a viscometer (10,000 s^-1^ for 1 min) and analyzed by flow cytometry. Levels of membrane GpIb were not different between vehicle- and ALA-treated platelets ([Figure 2A](#f2-1051660){ref-type="fig"}); rather, pre-treatment with the n-3 FA preserved GpIb levels, as shown by higher fluorescence values, suggesting it had an inhibitory effect on GpIb cleavage, as previously shown by our group.^[@b19-1051660]^

![High-shear induces von Willebrand factor binding in platelet-rich plasma but not in washed platelets. (A) Washed platelets were exposed to high-shear flow and analyzed for GpIb abundance by flow cytometry, which did not reveal any difference between vehicle- and α-linolenic acid (ALA)-treated platelets (n=3). MFI: mean fluorescence intensity. (B) Platelet-rich plasma was either left untreated or exposed to high-shear flow, and platelet-bound von Willebrand factor (vWF) analyzed by flow cytometry. In both vehicle- and ALA-treated samples, high-shear flow induced vWF binding, as shown by a 3-fold increase compared to that of samples not exposed to the shear force (n=3, *P*\<0.05). (C) Exposing washed platelets (WP) to high-shear flow did not lead to vWF binding; addition of exogenous human vWF before shear exposure resulted in robust binding (n=3).](1051660.fig2){#f2-1051660}

Next, we analyzed whether the effect on GpIb-vWF binding was specific for GpIb, vWF, or both. Whole blood was pre-treated with ALA or vehicle for 1 h, followed by isolation of platelet-rich plasma and exposure to high-shear flow (10,000 s^-1^ for 1 min). Flow cytometric analysis of platelet-bound vWF showed that pathological high-shear flow was able to induce GpIb-vWF binding, and that this was not influenced by the presence of ALA ([Figure 2B](#f2-1051660){ref-type="fig"}). When the same experiment was performed with washed platelets, we could not detect any platelet-bound vWF, demonstrating the plasmatic origin of the bound vWF ([Figure 2C](#f2-1051660){ref-type="fig"}); however, addition of exogenous human vWF to washed platelets was able to restore vWF-platelet binding ([Figure 2C](#f2-1051660){ref-type="fig"}). These results show that ALA has no effect on vWF itself, and suggest that its inhibitory effect is exerted through platelet GpIb and is specific for binding to anchored vWF (as typically exposed *in vivo* by endothelial cells after injury).

High resolution imaging of GpIb receptors at the plasma membrane of intact platelets was conducted using cryo-ET^[@b27-1051660]^ ([Figure 3A--C](#f3-1051660){ref-type="fig"}). Adherent platelets were incubated with anti-GpIb antibodies decorated with 6-nm gold-protein A and imaged with cryo-ET. The coordinates of the gold nanoclusters were identified ([Figure 3A--C](#f3-1051660){ref-type="fig"}). While the overall number of receptors per platelet did not differ significantly (115±50 per μm^2^ for the adherent platelets *vs*. 130±50 per μm^2^ in the case of the shear-activated platelets), the distribution of receptors varied. To quantify these changes, we analyzed the clustering properties of GpIbα by calculating, for each receptor, the number of receptors within a 50 nm radius. [Figure 3E--G](#f3-1051660){ref-type="fig"} shows normal distributions of neighborhood receptors, with an average of 2.5±1.8 neighbors for the adherent platelets, 3±2.3 neighbors for the shear-activated platelets and 3±1.8 for ALA-treated platelets. While the global distribution of receptors remained similar, 9% of the receptors (41/453) in the shear-activated platelets had ≥12 neighbors ([Figure 3F](#f3-1051660){ref-type="fig"}), while in the case of platelets treated with ALA only 3.8% of receptors (14/366) had more than 12 neighbors ([Figure 3G](#f3-1051660){ref-type="fig"}). As a control, we analyzed the density and number of neighbors of the platelet integrin αIIbβ3. This analysis showed a much higher density of integrin receptors (450±180 per μm^2^) and with many neighbors in comparison to the GpIb receptors (10±5 per μm^2^) ([Figure 3D, H](#f3-1051660){ref-type="fig"} and *Online Supplementary Figure S3*), which is in agreement with the difference in abundance of the two receptors in platelets.^[@b28-1051660]^

![High-shear induces a local rearrangement of GpIb as revealed by cryo-electron tomography. (A--C) Immunogold labeling and (E--G) neighborhood analysis for the control (A, E), shear-activated (B, F) and α-linolenic acid (ALA)-treated shear-activated (C, G) platelets. (A--C): Projection images (\~70 nm in thickness) obtained from tomograms of platelets on which GpIbα has been labeled with immunogold. The labeling was detected with protein G conjugated to 6 nm gold. To make the gold identification easier, the gold has been labeled with red circles. The yellow arrows indicate crowded neighborhoods in the pictures. All the projections have the same scale and the scale bar in A is 100 nm. (E--G) Analysis of the immunogold labeling. The three-dimensional coordinates of the 6 nm gold particles from six tomograms for each condition were selected and the distances to the "neighboring receptors" within a radius of 50 nm were calculated. The number of neighbors each receptor has is depicted in the histogram. (D) Integrin αIIbβ3 immunogold labeling was performed on spread platelets and (H) the same neighboring analysis performed.](1051660.fig3){#f3-1051660}

Analysis of immunofluorescent-stained GpIbα by GSD super-resolution microscopy also revealed that GpIb is abundantly expressed over the whole platelet membrane with small local points of high density ([Figure 4A](#f4-1051660){ref-type="fig"}). To compare the GSD microscopy and cryo-ET findings, we adopted a recently developed strategy.^[@b29-1051660]^ We used an assembly of the cryo-ET data into a 5 μm x 5 μm collage in which the coordinates of the 6 nm gold-labeled GpIb were drawn as red dots and blurred to 20 nm resolution to match the GSD data ([Figure 4B](#f4-1051660){ref-type="fig"}). The obtained synthetic model of platelet perimeter showed a distribution and appearance of the receptor in agreement with the fluorescence data, with a high density of GpIb throughout the membrane, but, interestingly, also local, small regions of more densely packed complexes ([Figure 4B](#f4-1051660){ref-type="fig"}, arrowhead). Pre-treating blood with ALA did not cause a change in the distribution of membrane GpIb detected by total internal reflection fluorescence (TIRF), likely due to the small size of GpIb clusters, which is in the same range as the resolution of the technique ([Figure 5](#f5-1051660){ref-type="fig"}).

![Comparison of GpIb labeling by super-resolution microscopy and cryo-electron tomography reveals a similar receptor distribution. (A) The GpIb receptors in shear-activated platelets were labeled and imaged by ground state depletion (GSD) as described in the Methods. (B) In order to compare the localization of the receptors determined by cryo-electron tomography and GSD microscopy, a synthetic model of platelet perimeter was generated by merging 17 tomograms from the gold-labeled platelets. The gold particle coordinates from the synthetic platelets were filtered to the same resolution as the GSD (20 nm), represented here in red. White arrowheads indicate local clustering areas. Scale bar: 2.5 μm for both A and B.](1051660.fig4){#f4-1051660}

![Analysis of GpIb distribution by total internal reflection microscopy. (A-D) Superresolution analysis of GpIb in platelets treated with vehicle (A), α-linolenic acid (ALA) (B) or methyl-b cyclodextrin (MbCD) (C) showed no detectable differences in the distribution of the receptor as measured by particle size (D). Scale bar: 2.5 μm.](1051660.fig5){#f5-1051660}

Discussion
==========

ALA is a plant-derived n-3 FA readily available in certain plant oils such as flaxseed, soybean and canola oil. Epidemiological studies have shown an inverse correlation between dietary ALA and cardiovascular events,^[@b11-1051660],[@b30-1051660],[@b31-1051660]^ although the molecular mechanisms of this protection are not completely known. Our group has investigated the molecular basis of several cardio-protective effects of ALA, showing that at least some of its effects are mediated by its action on endothelial cells, leukocytes and platelets.^[@b9-1051660],[@b10-1051660],[@b19-1051660]^ In this study, we have focused in particular on platelet adhesion to vWF under high-shear conditions, which represents the first step mediating platelet activation under arterial flow and is especially important in stenosed (atherosclerotic) arteries, where shear can reach extremely high values (\>5,000 s^−1^).^[@b7-1051660],[@b32-1051660],[@b33-1051660]^

Here we show for the first time that ALA is able to partially inhibit platelet adhesion to vWF under a shear flow of 10,000 s^−1^, when whole blood is pre-incubated for 1 h with ALA at dietary relevant concentrations.^[@b23-1051660]^ This is accompanied by an increase in speed and distance traveled by ALA-treated platelets, compared to vehicle-treated platelets ([Figure 1](#f1-1051660){ref-type="fig"}), and extends previous results from our group showing a reduced aggregation of citrated platelets over collagen at low shear.^[@b19-1051660]^ The effect observed is specific to anchored vWF, since vWF binding upon exposure of platelet-rich plasm to high-shear flow could not be altered by ALA pre-treatment ([Figure 2](#f2-1051660){ref-type="fig"}). A similar inhibition of platelet adhesion was obtained with the longer, marine-derived n-3 FA eicosapentaenoic acid, while the saturated fatty acid stearic acid had no effect (*Online Supplementary Figure S4*). Although the inhibitory effect of ALA may seem small (25% reduction in platelet adhesion), its biological implications are important, since inhibition at this early step will reduce the number of platelets activated in response to GpIb engagement and subsequent signaling leading to thrombus formation. The additional inhibitory effects of ALA at the level of intracellular signaling and granule secretion will lead, overall, to a greater effect with a relevant biological significance on atherothrombosis.

Since platelet binding to vWF is mediated by the GpIb receptor, we employed state-of-the-art methods (superresolution microscopy by GSD and cryo-ET) to analyze GpIb distribution on the platelet membrane at high-resolution.

The GpIb distribution analysis by cryo-ET suggests that a significant subpopulation of receptors clustered into a high number of neighbours in the shear activated (and to a lesser extent in the ALA-treated) platelets, indicating that platelet exposure to shear stress induces a local rearrangement of GpIb at the platelet plasma membrane, forming discrete small regions of high receptor density ([Figure 3](#f3-1051660){ref-type="fig"}). These regions presumably represent high affinity "binding units" or even binding loci for anchoring multimeric vWF.

Our observations are in line with previous findings^[@b34-1051660]^ showing that under high-shear stress platelets form local points of adhesion, termed "discrete adhesion points", which are the putative regions of interaction between platelets/vWF. Our functional and structural data provide a high-resolution insight into the position of the GpIb receptors and support a model where high-shear stress induces a rapid, local rearrangement of GpIb receptors into small "clusters" of 15-20 complexes. This subpopulation of receptors may represent the previously described high-affinity binding units that interact with vWF and enable platelet rolling under arterial flow. Pre-incubation of platelets with ALA reduces the local clustering of GpIb receptors as shown by the virtual absence of larger complexes (GPIb with ≥17 neighbors) ([Figure 3C, G](#f3-1051660){ref-type="fig"}). On the functional side, this provides an explanation as to why adhesion is significantly inhibited by ALA pre-treatment while platelet rolling speed is increased ([Figure 1A, C](#f1-1051660){ref-type="fig"}). Previous work has shown that ω-3 FA (of marine origin) can inhibit protein palmitoylation and, therefore, localization to lipid rafts.^[@b35-1051660]^ Although in our experiments the pre-incubation time was too short to achieve an analog effect, long-term, nutritional supplementation with ALA may also inhibit GpIb localization to lipid rafts via reduced palmitoylation and, consequently, reduce platelet adhesion to vWF even more through this additional mechanism.

Taken together, these data provide insight into the possible mechanism of the anti-thrombotic properties of n-3 FA in the early phase of thrombosis at sites of arterial stenosis or plaque. It may therefore represent the basis for a therapeutic approach that interferes with this process.

In conclusion, our structural data from intact platelets, including cryo-ET and super-resolution microscopy, show that upon high-shear conditions platelet GpIb receptors reorganize into "clusters" of 10 to 20 complexes closer to each other than on resting platelets; functionally, we demonstrate that, through intervention with the plant-derived n-3 FA ALA, the size of these clusters is decreased, thereby reducing platelet adhesion to vWF under high-shear flow. This highlights the potential of ALA as an anti-thrombotic agent.
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